AstraZeneca News Monitoring

Astrazeneca invests in China: $8B in deals, $2.5B in R&D center

Astrazeneca plc is investing heavily in China, signing two R&D deals, worth up to about $8 billion in up-front payments and milestones combined, with Chinese companies Harbour Biomed Ltd. and Syneron Bio, establishing a joint venture with Shenzhen …

AstraZeneca signs strategic partnership with Beijing; invests $2.5bn

AstraZeneca and GKS shares have legs, but the weight loss titans...

AstraZeneca PLC (LSE:AZN) and GSK PLC (LSE:GSK, NYSE:GSK) remain among Berenberg’s top picks in the pharmaceuticals sector, with the broker reaffirming its 'buy' rating on both stocks. The former carries a target price of £140, while the valuation …

AstraZeneca Makes Potential $10B+ China Commitment Despite Political Pressure

AstraZeneca is betting big money on China, unveiling plans to establish a new global strategic center in the country, alongside a pair of high-value deals with Chinese biotechs. With potential milestone payments, the pharma is putting more than $10 billion …

Pickleball Fights Severe Asthma For AstraZeneca's Fasenra

Teaming with the Professional Pickleball Association (PPA) in a multiyear deal, AstraZeneca’s seven-year-old Fasenra asthma medication has launched its first-ever sports partnership. The brand began the relationship as presenting sponsor of the Texas Open …

Covington & Burling counsels AstraZeneca on biotech company acquisition

The company focuses on in vivo cell therapies that have shown promise in early clinical activity. The company focuses on in vivo cell therapies that have shown promise in early clinical activity. International law firm Covington & Burling has guided …

AstraZeneca to invest $2.5bn in R&D centre in China

AstraZeneca has announced a $2.5bn investment in the company’s sixth worldwide strategic research and development (R&D) centre in Beijing, China. The initiative, which will take place up to 2029, is part of a strategic collaboration with the Beijing …

AstraZeneca to Establish Global Drug Research Center in Beijing

The investment, which will be spread over the next five years, is part of a strategic partnership with the Beijing Municipal Government and the Beijing Economic-Technological Development Area Administrative Office and includes several research and …

AstraZeneca announces $2.5bn investment in China to boost R&D capabilities

AstraZeneca (AZ) has said it will be investing $2.5bn in China over the next five years to “further advance life sciences” in the country. The investment includes a new global research and development (R&D) centre designed to advance AZ’s early-stage …

Prediction: 12 months from now, AstraZeneca’s share price could be…

After rising by over 20% since November, the AstraZeneca (LSE:AZN) share price is on a good run. And now management has just signed a $1bn deal to acquire EsoBiotec and further secure its long-term cancer therapy product portfolio. So, with the pharma …

AstraZeneca to Invest in R&D Centre in Beijing

AstraZeneca announced that it will invest $2.5 billion to establish a research and development (R&D) center in Beijing. This expansion comes just months after the British pharmaceutical giant faced regulatory scrutiny over import duties in China. …

Harbour BioMed inks global strategic collaboration with AstraZeneca to discover and develop next-generation therapeutic ...

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics in immunology and oncology, announced a global strategic collaboration with AstraZeneca to discover and develop …

AstraZeneca announces investment of $2.5 B to establish sixth global strategic R&D centre in China

AstraZeneca announces investment of $2.5 B to establish sixth global strategic R&D centre in China March 24, 2025 | Monday | News Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai image credit- shutterstock British …

AstraZeneca to invest $2.5 billion in new global strategic R&D centre, biotech agreements and manufacturing in Beijing

AstraZeneca announced an investment of $2.5 billion in Beijing to establish its sixth global strategic R&D centre together with major research and manufacturing agreements that will further advance life sciences in China. This investment over the next …

After China probe, is AstraZeneca’s new US$2.5 billion plan a blueprint for foreign firms?

Biopharmaceutical multinational AstraZeneca is not letting a bumpy 2024 dictate its path forward in China, and in the wake of a recent controversy emerges a multibillion-dollar commitment to China-based research – plus the company’s first vaccine- …

Fatty liver disease linked to higher mortality risk from many common diseases

A comprehensive study from Karolinska Institutet shows that people with fatty liver disease have almost twice the mortality rate of the general population. They have an increased risk of dying from both liver diseases and common diseases such as cancer and …

Fatty liver linked to increased risk of death from several diseases

A comprehensive study from Karolinska Institutet shows that people with fatty liver disease have almost twice the mortality rate of the general population. They have an increased risk of dying from both liver diseases and common diseases such as cancer and …

Increased Risk of Death Linked to Fatty Liver Disease

It is estimated that one in five people in Sweden has fatty liver disease known as MASLD (metabolic dysfunction-associated steatotic liver disease), and globally it may be as many as one in four. The disease is caused by overweight or obesity and is …

AstraZeneca receives CDSCO approval for Durvalumab in treating limited-stage small cell Lung Cancer

Bangalore: AstraZeneca Pharma India Ltd. has received approval from the Central Drugs Standard Control Organisation (CDSCO) to import and distribute Durvalumab (120 mg/2.4 mL and 500 mg/10 mL solution for infusion) for a new indication. The drug is …

Global Uveitis Treatment Market Insights 2025: Key Trends, Market Size, And Growth Forecast

The Business Research Company’s Uveitis Treatment Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /⁨EINPresswire.com⁩/ -- The uptick in the uveitis treatment market …

Key Market Driver In VELETRI Industry 2025: Growing PAH Cases Drive Need For Advanced Therapeutic Solutions

The Business Research Company’s VELETRI Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /⁨EINPresswire.com⁩/ -- What's the Current State of the VELETRI Market? The …

Top Growth Driver In The Uveal Neoplasms Market 2025: Rising Incidence Of Eye Cancer And Its Impact On The Market

The Business Research Company’s Uveal Neoplasms Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /⁨EINPresswire.com⁩/ -- How has the Uveal Neoplasms Market performed …

Global Upadacitinib Market Forecast: Key Growth Drivers, Trends, And Opportunities From 2025 To 2034

The Business Research Company’s Upadacitinib Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /⁨EINPresswire.com⁩/ -- The upadacitinib market has skyrocketed in recent …

Global Vulvovaginal Candidiasis Treatment Market Outlook 2025-2034: Growth Drivers, Share, And Trends

The Business Research Company's Vulvovaginal Candidiasis Treatment Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /⁨EINPresswire.com⁩/ -- Get 20% off on …

Periodontal Disease Treatment Global Market Predicts Strong Growth, Reaching $2.20 Billion By 2029

Periodontal Disease Treatment Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /⁨EINPresswire.com⁩/ -- Get 20% off on Global Market Reports until March 31st! Use …

Comprehensive Insights Of The Global Turner Syndrome Market: Key Drivers, Trends, Growth, And Forecast For 2025-2034

The Business Research Company’s Turner Syndrome Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /⁨EINPresswire.com⁩/ -- What Is Driving the Turner Syndrome Market …

Peripheral Neuritis Treatment Global Market: Robust Growth Forecasted Due To Rising Prevalence Of Diabetes

Peripheral Neuritis Treatment Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /⁨EINPresswire.com⁩/ -- Get 20% off on Global Market Reports until March 31st! Use code …

Zika Virus Therapeutics Market Forecast 2025-2034: Analyzing Growth Drivers, Market Share, Segments, And Emerging Trends

The Business Research Company's Zika Virus Therapeutics Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /⁨EINPresswire.com⁩/ -- Get 20% off on Global Market …

Peripheral T Cell Lymphoma Global Market Report 2025: A Comprehensive Forecast & Insight

Peripheral T Cell Lymphoma Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /⁨EINPresswire.com⁩/ -- Get 20% off on Global Market Reports until March 31st! Use …

Vyndaqel Global Market Report 2025: Comprehensive Insights and Detailed Forecast

The Business Research Company's Vyndaqel Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /⁨EINPresswire.com⁩/ -- Get 20% off on Global Market Reports until March …

Triple Negative Breast Cancer Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034

The Business Research Company’s Triple Negative Breast Cancer Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /⁨EINPresswire.com⁩/ -- The triple negative breast cancer market …

Global West Syndrome Market: Key Trends, Market Share, Growth Drivers, And Forecast For 2025-2034

The Business Research Company's West Syndrome Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /⁨EINPresswire.com⁩/ -- Get 20% off on Global Market Reports …

Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Market 2025: Rising Prevalence of Parkinson’s Disease Driving Growth

The Business Research Company's Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /⁨EINPresswire.com⁩/ -- Get 20% …

In-Depth Analysis Of The Global Vutrisiran Market: Key Drivers, Trends, Growth Opportunities, And Forecast 2025-2034

The Business Research Company's Vutrisiran Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /⁨EINPresswire.com⁩/ -- Get 20% off on Global Market Reports until …

Global Pelvic Inflammatory Disease Treatment Market Forecast: Key Growth Drivers, Trends, And Opportunities To 2034

Pelvic Inflammatory Disease Treatment Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /⁨EINPresswire.com⁩/ -- Get 20% off on Global Market Reports until March …

Global Peptide And Anticoagulant Drugs Market Insights 2025: Key Trends, Market Size, And Growth Forecast

Peptide And Anticoagulant Drugs Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /⁨EINPresswire.com⁩/ -- Get 20% off on Global Market Reports until March 31st! …

Vertigo Treatment Market Forecast 2025-2034: Insights On Market Size, Growth Trends And Competitive Landscape

The Business Research Company's Vertigo Treatment Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /⁨EINPresswire.com⁩/ -- Get 20% off on Global Market …

The Pediatric Drugs Global Market Report 2025: Comprehensive Analysis Of The Industry's Future Outlook

Pediatric Drugs Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /⁨EINPresswire.com⁩/ -- Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at …

Comprehensive Insights Of The Global Pediatric Growth Hormone Deficiency Market: Key Drivers, Trends, And Forecast

Pediatric Growth Hormone Deficiency Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /⁨EINPresswire.com⁩/ -- Secure 20% discount on Global Market Reports until …